Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
To assess the potential association between pioglitazone and bladder cancer compared with
non-pioglitazone users among patients with type 2 diabetes mellitus.
Details
Lead Sponsor:
Takeda
Collaborators:
Department of Epidemiology at University of Pennsylvania Kaiser Permanente